MED
MEDIFAST INC
11.90$
-0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -64.8% | -30.8% | +79.5% | -30.6% | -154.5% | – | -199.2% | – | -143.6% | – | +552.7% | – | |
| – | -1.7% | -2.7% | -5.9% | +4.1% | -0.3% | +3.0% | +23.3% | -14.7% | +0.4% | +0.5% | -1.1% | – | |
| – | -10.5% | -9.3% | +13.0% | -75.3% | +251.8% | -9.5% | +36.1% | -65.4% | +138.7% | -12.7% | -4.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -254.9% | – | – | – | -514.6% | – | – | – | -169.2% | – | – | – | |
| – | -43.6% | +94.6% | +5.3% | -28.3% | +64.4% | -33.4% | -9.5% | -1.1% | -0.9% | -18.9% | -11.6% | – | |
| – | -78.7% | -74.1% | -8.8% | -29.6% | +990.4% | -89.4% | – | -206.9% | -65.3% | +246.1% | -92.8% | – | |
| – | -0.4% | -96.1% | -99.4% | -75.0% | +71,400.0% | -72.9% | -99.5% | +19,400.0% | +0.0% | -55.4% | -4.6% | – | |
| – | -90.9% | +8,070.0% | -98.0% | -87.5% | -50.0% | +36,800.0% | -99.7% | – | -99.7% | -81,500.0% | – | – | |
| – | -1.4% | -91.7% | -98.7% | -85.0% | -66.7% | +56,200.0% | -99.6% | +28,150.0% | – | -90,200.0% | -90.8% | – | |
| – | – | – | +247.9% | -30.9% | -434.4% | – | +1,164.5% | -121.7% | – | – | – | – | |
| – | -66.1% | -43.2% | +104.6% | -31.0% | -194.1% | – | -352.4% | – | -161.7% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.